COMMUNIQUÉS West-GlobeNewswire

AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet
25/06/2026
Favourable safety profile in marked contrast to traditional inotropic therapeutics AC01 showed rapid and sustained numerical improvements in cardiac output, structure and function STOCKHOLM, Sweden, June 25, 2026 – [...]
Young workers willing to make career trade-offs for jobs with pensions: new research from HOOPP and Abacus Data
25/06/2026
TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- In an economy where young people feel increasing uncertainty about housing, saving money and the cost of living, nearly two-thirds of Canadians under the age of 35 say they [...]
Un nouveau projet de l’ACE pour soutenir les ergothérapeutes diplômés à l’étranger au Canada
25/06/2026
OTTAWA, Ontario, 25 juin 2026 (GLOBE NEWSWIRE) -- Un nouvel effort national est en cours afin de mieux soutenir les ergothérapeutes formés à l’étranger (EFE) dans l'avancement de leur carrière au Canada. L’Association [...]
Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer
25/06/2026
Brings more than 25 years of global drug development, regulatory and strategic leadership experience successfully guiding innovative therapies from clinical development through regulatory approval and commercialization [...]
IBA to install the first proton therapy center in Brazil in Rio de Janeiro
25/06/2026
Louvain-La-Neuve, Belgium, June 25, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment [...]
Press Release: Sanofi Foundation opens new chapter centered on future generations
25/06/2026
Sanofi Foundation opens new chapter centered on future generations Paris, June 2 5 , 2026 . The Sanofi Foundation is opening a new chapter with a strengthened commitment to children and young people, particularly those [...]
AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet
25/06/2026
Favourable safety profile in marked contrast to traditional inotropic therapeutics AC01 showed rapid and sustained numerical improvements in cardiac output, structure and function STOCKHOLM, Sweden, June 25, 2026 – [...]
Communiqué de presse : La Fondation Sanofi ouvre un nouveau chapitre centré sur les générations futures
25/06/2026
La Fondation Sanofi ouvre un nouveau chapitre centré sur les générations futures Paris, 25 juin 2026 . La Fondation Sanofi ouvre un nouveau chapitre avec un engagement renforcé en faveur des enfants et des jeunes, en [...]
Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
25/06/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 25, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]
IBA va installer le premier centre de protonthérapie du Brésil, à Rio de Janeiro
25/06/2026
Louvain-la-Neuve, Belgique, le 25 juin 2026 - IBA (Ion Beam Applications S.A., EURONEXT), leader mondial des technologies d’accélération de particules et principal fournisseur de solutions de protonthérapie pour le [...]
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
25/06/2026
DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
Revolution Medicines to Present Clinical Data from RAS(ON) Inhibitor Combination Trials in Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026
25/06/2026
REDWOOD CITY, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that four oral [...]
Mesoblast Draws US$50 Million from Five-Year Non-Dilutive Facility
25/06/2026
Optimized capital structure, retiring short-term maturing debt Well-funded for commercial operations and growth pipeline NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global [...]
TWL Introduces Virtual Tirzepatide Assessment Program for Eligible Weight-Management Patients
25/06/2026
New digital-care process connects clinical evaluation, coverage assistance, pharmacy coordination and continuing provider support New York, NY, June 24, 2026 (GLOBE NEWSWIRE) -- TWL today announced the introduction of a [...]
FitRx Introduces Streamlined Tirzepatide Evaluation and Care Program
25/06/2026
New virtual-care process coordinates medical review, prescription support, insurance navigation and ongoing follow-up for eligible weight-management patients New York, NY, June 24, 2026 (GLOBE NEWSWIRE) -- FitRx [...]
HUTCHMED Highlights Pivotal Phase II Data for Fanregratinib in Intrahepatic Cholangiocarcinoma Presented at ESMO Gastrointestinal Cancers Congress 2026
25/06/2026
— Registration-enabling study demonstrated high clinically meaningful objective responses, achieving rapid and durable disease control — — Fanregratinib holds promise as a new treatment option for pretreated advanced [...]
Prometheuz Introduces Online Testosterone Replacement Therapy Platform for U.S. Men Experiencing Low Testosterone
24/06/2026
New York, USA, June 24, 2026 (GLOBE NEWSWIRE) -- Prometheuz announced the launch of its online testosterone replacement therapy (TRT) platform designed to connect men across the United States with licensed clinicians [...]
ARS Pharmaceuticals Provides Commercial and Financial Updates
24/06/2026
No new commercial formulary additions or coverage decisions issued for neffy ® (epinephrine nasal spray) in the July 1, 2026 cycle; company to continue payer discussions for potential future inclusion Total 2026 cash- [...]
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
24/06/2026
DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]

Pages